UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

SCHEDULE 13G/A
Amendment No. 13

Under the Securities Exchange Act of 1934*

China Cord Blood Corporation
(Name of Issuer)

Common Stock, par value $0.0001 per share
(Title of Class of Securities)

698659109
(CUSIP Number)

December 31, 2017
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).
 


CUSIP No.
698659109
 
1
NAME OF REPORTING PERSON
 
 
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
 
 
JHMS Fund , LLC (47-4524143)
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
(a)
   
(b)☒
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Delaware
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5
SOLE VOTING POWER
 
 
0
 
 
 
 
6
SHARED VOTING POWER
 
 
13,280,000*
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
13,280,000*
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
13,280,000* (see Item 4)
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
Not Applicable
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
 
11.69%**
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
* Includes 12,751,500 shares of common stock, par value $0.0001 per share, and 528,500 derivative call rights held by JHMS Management, LLC and Jayhawk Capital Management, L.L.C., and exercisable within 60 days of this report.
** Percent of class is based on 113,524,742 outstanding shares of common stock, par value $0.0001 per share as of September 30, 2017 as reported by China Cord Blood Corporation on its Form 6-K/A filed on December 6, 2017.
 
1

CUSIP No.
698659109
 
1
NAME OF REPORTING PERSON
 
 
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
 
 
JHMS Management, LLC (47-4524095)
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
(a)
   
(b)☒
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Delaware
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5
SOLE VOTING POWER
 
 
0
 
 
 
 
6
SHARED VOTING POWER
 
 
13,280,000*
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
13,280,000*
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
13,280,000* (see Item 4)
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
Not Applicable
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
 
11.69%**
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
* Includes 12,751,500 shares of common stock, par value $0.0001 per share, and 528,500 derivative call rights held by JHMS Fund, LLC, and Jayhawk Capital Management, L.L.C., and exercisable within 60 days of this report.
** Percent of class is based on 113,524,742 outstanding shares of common stock, par value $0.0001 per share as of September 30, 2017 as reported by China Cord Blood Corporation on its Form 6-K/A filed on December 6, 2017.
 
2

CUSIP No.
698659109
 
1
NAME OF REPORTING PERSON
 
 
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
 
 
Jayhawk Capital Management, L.L.C. (48-1172612)
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
(a)
   
(b)☒
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Delaware
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5
SOLE VOTING POWER
 
 
0
 
 
 
 
6
SHARED VOTING POWER
 
 
13,280,000*
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
13,280,000*
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
13,280,000* (see Item 4)
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
Not Applicable
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
 
11.69%**
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
* Includes 12,751,500 shares of common stock, par value $0.0001 per share, and 528,500 derivative call rights held by JHMS Fund, LLC, and JHMS Management, LLC, and exercisable within 60 days of this report.
** Percent of class is based on 113,524,742 outstanding shares of common stock, par value $0.0001 per share as of September 30, 2017 as reported by China Cord Blood Corporation on its Form 6-K/A filed on December 6, 2017.
 
3

CUSIP No.
698659109
 
1
NAME OF REPORTING PERSON
 
 
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
 
 
Jayhawk Private Equity Fund II, L.P. (26-1692972)
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
(a)
   
(b)☒
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Delaware
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5
SOLE VOTING POWER
 
 
0
 
 
 
 
6
SHARED VOTING POWER
 
 
2,686,300*
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
2,686,300*
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
2,686,300* (see Item 4)
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
Not Applicable
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
 
1.93%**
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 
* Includes 2,686,300 shares of common stock, par value $0.0001 per share, held by Jayhawk Private Equity GP II, L.P. and Jayhawk Private Equity, LLC
** Percent of class is based on 113,524,742 outstanding shares of common stock, par value $0.0001 per share as of September 30, 2017 as reported by China Cord Blood Corporation on its Form 6-K/A filed on December 6, 2017.
 
4

CUSIP No.
698659109
 
1
NAME OF REPORTING PERSON
 
 
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
 
 
Jayhawk Private Equity GP II, L.P. (26-1692915)
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
(a)
   
(b)☒
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Delaware
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5
SOLE VOTING POWER
 
 
0
 
 
 
 
6
SHARED VOTING POWER
 
 
2,686,300*
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
2,686,300*
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
2,686,300* (see Item 4)
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
Not Applicable
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
 
1.93%**
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 
* Includes 2,686,300 shares of common stock, par value $0.0001 per share, held by Jayhawk Private Equity Fund II, L.P. and Jayhawk Private Equity, LLC
** Percent of class is based on 113,524,742 outstanding shares of common stock, par value $0.0001 per share as of September 30, 2017 as reported by China Cord Blood Corporation on its Form 6-K/A filed on December 6, 2017.
 
5

CUSIP No.
698659109
 
1
NAME OF REPORTING PERSON
 
 
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
 
 
Jayhawk Private Equity, LLC (26-1692786)
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
(a)
   
(b)☒
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Delaware
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5
SOLE VOTING POWER
 
 
0
 
 
 
 
6
SHARED VOTING POWER
 
 
2,686,300*
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
2,686,300*
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
2,686,300* (see Item 4)
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
Not Applicable
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
 
1.93%**
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
* Includes 2,686,300 shares of common stock, par value $0.0001 per share, held by Jayhawk Private Equity Fund II, L.P. and Jayhawk Private Equity GP II, L.P.
** Percent of class is based on 113,524,742 outstanding shares of common stock, par value $0.0001 per share as of September 30, 2017 as reported by China Cord Blood Corporation on its Form 6-K/A filed on December 6, 2017.
 
6

CUSIP No.
698659109
 
1
NAME OF REPORTING PERSON
 
 
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
 
 
Kent C McCarthy Revocable Trust dated October 24, 2003
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
(a)
   
(b)☒
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Kansas
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5
SOLE VOTING POWER
 
 
0
 
 
 
 
6
SHARED VOTING POWER
 
 
159,400
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
159,400
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
159,400 (see Item 4)
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
Not Applicable
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
 
0.14%*
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
* Percent of class is based on 113,524,742 outstanding shares of common stock, par value $0.0001 per share as of September 30, 2017 as reported by China Cord Blood Corporation on its Form 6-K/A filed on December 6, 2017.
 
7

CUSIP No.
698659109
 
1
NAME OF REPORTING PERSON
 
 
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
 
 
Kent C. McCarthy
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
(a)
   
(b)☒
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
United States of America
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5
SOLE VOTING POWER
 
 
0
 
 
 
 
6
SHARED VOTING POWER
 
 
16,125,700*
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
16,125,700*
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
16,125,700* (see Item 4)
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
Not Applicable
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
 
14.20%**
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
IN
 
 
 
 
*Includes 2,686,300 shares of common stock, par value $0.0001 per share, held by Jayhawk Private Equity Fund II, L.P., 13,280,000 shares of common stock, par value $0.0001 per share, held by JHMS Fund, LLC, and 159,400 shares of common stock, par value $0.0001 per share, held by the Kent C. McCarthy Revocable Trust dated October 24, 2003.
** Percent of class is based on 113,524,742 outstanding shares of common stock, par value $0.0001 per share as of September 30, 2017 as reported by China Cord Blood Corporation on its Form 6-K/A filed on December 6, 2017.
 
8

Item 2(a)
Name of Person Filing:

This Schedule 13G/A is being jointly filed by Kent C. McCarthy (“Mr. McCarthy”), JHMS Fund, LLC a Delaware limited liability company (“JHMS Fund”), JHMS Management, LLC, a Delaware limited liability company (“JHMS Management”), Jayhawk Capital Management, L.L.C., a Delaware limited liability company (“JCM”), Jayhawk Private Equity, LLC, a Delaware limited liability company (“JPE”), Jayhawk Private Equity GP II, L.P., a Delaware limited partnership (“JPEGP”), Jayhawk Private Equity Fund II, L.P., a Delaware limited Partnership (“JPEF”), the Kent C. McCarthy Revocable Trust dated October 24, 2003 created under the laws of the state of Kansas (the “Revocable Trust”).

Mr. McCarthy, JHMS Fund, JHMS Management, JCM, JPE, JPEGP, JPEF, and the Revocable Trust have entered into an Agreement Regarding Joint Filing of 13G (the “Agreement”) pursuant to which  Mr. McCarthy, JHMS Fund, JHMS Management, JCM, JPE, JPEGP, JPEF, and the Revocable Trust have agreed to file this 13G jointly and in accordance with the provisions of Rule 13d-1(k)(1) of the Securities Exchange Act of 1934 as amended (the “Act”).  A copy of the Agreement is attached hereto as Exhibit A.

Item 2(b)
Address of Principal Business Office or, if None, Residence:

13021 W 74th Street, Shawnee, KS 66216

Item 2(c)
Citizenship:

Mr. McCarthy is a citizen of the United States of America, JHMS Fund is a Delaware limited liability company, JHMS Management is a Delaware limited liability company, JCM is a Delaware limited liability company, JPE is a Delaware limited liability company, JPEGP is a Delaware limited partnership, JPEF is a Delaware limited partnership, and the Revocable Trust is a trust created under the laws of the state of Kansas.

Item 4
Ownership:

The information below is as of December 31, 2017.

(a)
Amount beneficially owned:
1.
JHMS Fund, LLC: 13,280,000*
2.
JHMS Management, LLC: 13,280,000*
3.
Jayhawk Capital Management, L.L.C.: 13,280,000*
4.
Jayhawk Private Equity Fund II, L.P.: 2,686,300**
5.
Jayhawk Private Equity GP II, L.P.: 2,686,300**
6.
Jayhawk Private Equity, LLC: 2,686,300**
7.
Kent C McCarthy Revocable Trust dated October 24, 2003: 159,400
8.
Kent C. McCarthy: 16,125,700***

* Includes 12,751,500 shares of common stock, par value $0.0001 per share, and 528,500 derivative call rights held by JHMS Fund, LLC, JHMS Management, LLC and Jayhawk Capital Management, L.L.C., and exercisable within 60 days of this report.
** Includes 2,686,300 shares of common stock, par value $0.0001 per share, held by Jayhawk Private Equity Fund II, LLC, Jayhawk Private Equity GP II, L.P. and Jayhawk Private Equity, LLC
*** Includes 2,686,300 shares of common stock, par value $0.0001 per share, held by Jayhawk Private Equity Fund II, L.P., Jayhawk Private Equity GP II, L.P. and Jayhawk Private Equity, LLC; 13,280,000 shares of common stock, par value $0.0001 per share, held by JHMS Fund, LLC, JHMS Management, LLC and Jayhawk Capital Management, LLC; and 159,400 shares of common stock, par value $0.0001 per share, held by the Kent C. McCarthy Revocable Trust dated October 24, 2003.

(b)
Percent of class:
1.
JHMS Fund, LLC: 11.69%
2.
JHMS Management, LLC: 11.69%
3.
Jayhawk Capital Management, L.L.C.: 11.69%
4.
Jayhawk Private Equity Fund II, L.P.: 1.93%
5.
Jayhawk Private Equity GP II, L.P.: 1.93%
6.
Jayhawk Private Equity, LLC: 1.93%
7.
Kent C McCarthy Revocable Trust dated October 24, 2003: 0.14%
8.
Kent C. McCarthy: 14.20%

Percent of class is based on 113,524,742 outstanding shares of common stock, par value $0.0001 per share as of September 30, 2017 as reported by China Cord Blood Corporation on its Form 6-K/A filed on December 6, 2017.
 
9

(c)
Number of shares as to which the person has:

  (i)
Sole power to vote or to direct the vote:
1.
JHMS Fund, LLC: 0
2.
JHMS Management, LLC: 0
3.
Jayhawk Capital Management, L.L.C.: 0
4.
Jayhawk Private Equity Fund II, L.P.: 0
5.
Jayhawk Private Equity GP II, L.P.: 0
6.
Jayhawk Private Equity, LLC: 0
7.
Kent C McCarthy Revocable Trust dated October 24, 2003: 0
8.
Kent C. McCarthy: 0

  (ii)
Shared power to vote or direct the vote:
1.
JHMS Fund, LLC: 13,280,000*
2.
JHMS Management, LLC: 13,280,000*
3.
Jayhawk Capital Management, L.L.C.: 13,280,000*
4.
Jayhawk Private Equity Fund II, L.P.: 2,686,300**
5.
Jayhawk Private Equity GP II, L.P.: 2,686,300**
6.
Jayhawk Private Equity, LLC: 2,686,300**
7.
Kent C McCarthy Revocable Trust dated October 24, 2003: 159,400
8.
Kent C. McCarthy: 16,125,700***

  (iii)
Sole power to dispose or to direct the disposition of:
1.
JHMS Fund, LLC: 0
2.
JHMS Management, LLC: 0
3.
Jayhawk Capital Management, L.L.C.: 0
4.
Jayhawk Private Equity Fund II, L.P.: 0
5.
Jayhawk Private Equity GP II, L.P.: 0
6.
Jayhawk Private Equity, LLC: 0
7.
Kent C McCarthy Revocable Trust dated October 24, 2003: 0
8.
Kent C. McCarthy: 0

  (iv)
Shared power to dispose or to direct the disposition of:
1.
JHMS Fund, LLC: 13,280,000*
2.
JHMS Management, LLC: 13,280,000*
3.
Jayhawk Capital Management, L.L.C.: 13,280,000*
4.
Jayhawk Private Equity Fund II, L.P.: 2,686,300**
5.
Jayhawk Private Equity GP II, L.P.: 2,686,300**
6.
Jayhawk Private Equity, LLC: 2,686,300**
7.
Kent C McCarthy Revocable Trust dated October 24, 2003: 159,400
8.
Kent C. McCarthy: 16,125,700***

* Includes 12,751,500 shares of common stock, par value $0.0001 per share, and 528,500 derivative call rights held by JHMS Fund, LLC, JHMS Management, LLC and Jayhawk Capital Management, L.L.C., and exercisable within 60 days of this report.
** Includes 2,686,300 shares of common stock, par value $0.0001 per share, held by Jayhawk Private Equity Fund II, LLC, Jayhawk Private Equity GP II, L.P. and Jayhawk Private Equity, LLC
*** Includes 2,686,300 shares of common stock, par value $0.0001 per share, held by Jayhawk Private Equity Fund II, L.P., Jayhawk Private Equity GP II, L.P. and Jayhawk Private Equity, LLC; 13,280,000 shares of common stock, par value $0.0001 per share, held by JHMS Fund, LLC, JHMS Management, LLC and Jayhawk Capital Management, LLC; and 159,400 shares of common stock, par value $0.0001 per share, held by the Kent C. McCarthy Revocable Trust dated October 24, 2003.

Item 10
Certification:

By signing below each party certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
10

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, the parties below certify that the information set forth in this statement is true, complete and correct.

Dated:
February 13, 2018

 
/s/ Kent C. McCarthy
 
 
Kent C. McCarthy
 

 
JHMS Fund, LLC
     
   
By: JHMS Management, LLC
   
its Manager
     
   
/s/ Michael D. Schmitz
 
   
Name: Michael D. Schmitz
   
Title: Manager

 
JHMS Management, LLC
   
 
By:
/s/ Michael D. Schmitz
 
   
Name: Michael D. Schmitz
   
Title: Manager

 
Jayhawk Capital Management, LLC
 
       
 
By:
 /s/ Kent C. McCarthy
 
   
Name: Kent C. McCarthy
 
   
Title: Manager
 

 
Jayhawk Private Equity Fund II, L.P.
 
       
 
By:
Jayhawk Private Equity GP II, L.P.
 
    Its general partner  
       
    By: Jayhawk Private Equity, LLC  
    Its general partner  
       
    By: /s/ Kent C. McCarthy  
   
Name: Kent C. McCarthy
 
   
Title:  Manager
 

 
Jayhawk Private Equity GP II, L.P.
 
       
 
By:
Jayhawk Private Equity, LLC
 
   
Its general partner
 
     
    By: /s/ Kent C. McCarthy  
   
Name:  Kent C. McCarthy
 
   
Title: Manager
 

 
Jayhawk Private Equity, LLC
 
       
 
By:
 /s/ Kent C. McCarthy
 
   
Name:  Kent C. McCarthy
 
   
Title: Manager
 
 
 
Kent C. McCarthy Revocable Trust dated
October 24, 2003
 
       
 
By:
 /s/ Kent C. McCarthy
 
   
Name: Kent C. McCarthy
 
   
Title: Trustee
 
 
11

Exhibit A

AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13G/A

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G/A (including amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of China Cord Blood Corporation, and further agree that this Agreement be included as an exhibit to such filings.

In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 13th day of February, 2018.

 
/s/ Kent C. McCarthy
 
 
Kent C. McCarthy
 

 
JHMS Fund, LLC
   
   
By: JHMS Management, LLC
   
its Manager
     
   
/s/ Michael D. Schmitz
 
   
Name: Michael D. Schmitz
   
Title: Manager

 
JHMS Management, LLC
   
 
By:
/s/ Michael D. Schmitz
 
   
Name: Michael D. Schmitz
   
Title: Manager

 
Jayhawk Capital Management, LLC
 
       
 
By:
 /s/ Kent C. McCarthy
 
   
Name: Kent C. McCarthy
 
   
Title: Manager
 

 
Jayhawk Private Equity Fund II, L.P.
 
       
 
By:
Jayhawk Private Equity GP II, L.P.
 
   
Its general partner
 
       
    By: Jayhawk Private Equity, LLC  
    Its general partner  
       
    By: /s/ Kent C. McCarthy  
    Name: Kent C. McCarthy  
   
Title:  Manager
 

 
Jayhawk Private Equity GP II, L.P.
 
       
 
By:
Jayhawk Private Equity, LLC
 
    Its general partner  
     
    By: /s/ Kent C. McCarthy  
   
Name:  Kent C. McCarthy
 
   
Title: Manager
 

 
Jayhawk Private Equity, LLC
 
       
 
By:
 /s/ Kent C. McCarthy
 
   
Name:  Kent C. McCarthy
 
   
Title: Manager
 
 
 
Kent C. McCarthy Revocable Trust dated October 24, 2003
 
       
 
By:
 /s/ Kent C. McCarthy
 
   
Name: Kent C. McCarthy
 
   
Title: Trustee
 

 
12